S. Broadley

Associations between diet quality and depression, anxiety, and fatigue in multiple sclerosis.

L. Blizzard, A. Ponsonby, I. van der Mei, 2022, Multiple sclerosis and related disorders.

Antimycobacterial activity of 'Virkon'.

J. Furr, P. Jenkins, S. Broadley, 1993, The Journal of hospital infection.

Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis

A. Coulthard, S. Shakib, C. Kneebone, 2009, Multiple sclerosis.

Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.

J. Furr, P. Jenkins, S. Broadley, 1995, Journal of medical microbiology.

Could vitamin D be the answer to multiple sclerosis?

S. Broadley, 2007, Multiple sclerosis.

Results of a phase IIa clinical trial of an endogenous anti-inflammatory molecule , chaperonin 10 , in multiple sclerosis

S. Broadley, 3. Feeney, 3. Griffiths, 2010 .

Anti‐mycobacterial activity of biocides

J. Furr, S. Broadley, A. Russell, 1991 .

Higher dietary quality is prospectively associated with lower MRI FLAIR lesion volume, but not with hazard of relapse, change in disability or black hole volume in people with Multiple Sclerosis.

L. Blizzard, A. Ponsonby, J. Lechner-Scott, 2023, Multiple Sclerosis and Related Disorders.